Search

The article discusses the impact of endocrine-disrupting chemicals (EDCs) on hormonal health and how plastic items in households may contribute to these issues. Topics include Plastic-Free Lifestyle, exploring Helen's decision to eliminate plastic gifts due to environmental and health concerns; Hormonal Imbalance and EDCs, detailing how certain plastics and chemicals can exacerbate conditions like estrogen dominance and other hormonal disruptions; and Strategies for Reducing Exposure.

Karen Bridgman Much has been written about the management of premenstrual syndrome and it is said to affect up to 90 per cent of menstruating women in varying degrees of [...]

Anger is a normal and necessary emotion, but when it is not properly managed, it can lead to unhappiness, exhaustion, and damaged relationships. The summer heat can exacerbate anger, causing hostile behavior and even violent incidents. Women's anger has been increasing globally, but societal expectations often prevent women from expressing their anger openly. It is important to recognize and manage anger by setting boundaries, addressing the causes, and finding healthy outlets such as journaling, breathing exercises, and physical activity. [Extracted from the article]

2024 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in premenstrual syndrome. According to news reporting originating from Solan, [...]

This article from Woman & Home provides health advice from GP Dr. Pixie McKenna. The article addresses various health concerns, including premenstrual syndrome (PMS), thyroid problems, and ingrown toenails. For PMS, the contraceptive pill, antidepressants, hormone replacement, and lifestyle remedies are suggested as treatment options. The article also discusses the causes and remedies for hiccups. In addition, it advises a reader who is experiencing symptoms such as feeling cold, sluggishness, weight gain, heavy periods, and hair loss to consult a doctor for a possible thyroid problem. Lastly, the article warns against the risks of purchasing medications online and emphasizes the importance of consulting a trusted healthcare professional. [Extracted from the article]

Some folks, including those with bothersome PMS symptoms or PMDD may feel less drained with a serotonin reuptake inhibitor (SSRI), even with a short two-week monthly course, Dr. Eblen adds.[16] [17] Bottom line: You've likely been told forever that it's normal to intensely suffer during your period-and I'm here to tell you that, no, it is not. Exercise-like yoga, walking, swimming, and dancing-increases your heart rate and releases endorphins, which might make you feel a little better and more energized when PMS hits, according to Dr. Eblen.[14] [15] Finally, if you "feel crappy, just give yourself a break", Dr. Eblen says-ya know, take it easy and truly rest for a couple of days, and let your body do its thing. Your period can disrupt your sleep too-especially if your flow is on the heavier side and/or you've got particularly awful cramps, Dr. Eblen says.[7] (Good to know I'm not the only one who bolts awake with pain shooting across my lower abdomen at 3 a.m.) Basically, all of the emotional and physical turmoil that goes down during this hellish week or so can make you toss and turn, she adds. [Extracted from the article]

2023 NOV 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on premenstrual syndrome is the subject of a new report. According to [...]

The article suggests ways to help women cope with premenstrual dysphoric disorder (PMDD). Topics covered include the diagnostic criteria for PMDD, mental health resources that can help with managing PMDD, such as cognitive behavioral therapy, and how open communication with partner, friends and family may help lighten the burden.

A recent study conducted by researchers from Ibaraki University in Japan focused on understanding the diagnosis and treatment of Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Syndrome (PMS) among psychiatrists and clinical psychologists in Japanese university health services. The study found that few practitioners considered PMDD/PMS as a potential diagnosis or routinely inquired about a patient's menstruation, but when provided with information linking symptoms to the menstrual cycle, most considered PMDD and PMS as possible diagnoses. The research concluded that clinicians should consider PMDD/PMS when treating women with depressive symptoms. [Extracted from the article]

A patent application by Otsuka Pharmaceutical Co. Ltd. outlines an information provision method for predicting the health condition of consumers and supporting health maintenance and improvement. The method involves acquiring personal data, determining a segmentation based on health data, and providing health information tailored to the individual's health condition. The patent application emphasizes the importance of proactive and preventive healthcare, utilizing data analysis and artificial intelligence to predict and prevent future health issues. The application also highlights the correlation between lifestyle factors, genetic information, and health risks in order to provide personalized health recommendations. [Extracted from the article]

A recent study conducted by researchers at the All India Institute of Medical Sciences (AIIMS) explored the coexistence of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) in diagnostic manuals. The study found that while both disorders have substantial prevalence, PMDD is considered the more severe of the two. Through citation analysis, the researchers concluded that there is a need for a unique diagnostic entity to represent premenstrual disorders, suggesting that the coexistence of PMS and PMDD may be redundant. The study highlights the importance of understanding and distinguishing between these two conditions in diagnostic practices. [Extracted from the article]

A recent study conducted at Zanjan University of Medical Sciences explored the impact of group counseling based on positive psychology delivered through the WhatsApp platform on the severity of premenstrual syndrome (PMS) symptoms. Participants in the intervention group experienced a significant decrease in PMS symptoms immediately and two months post-intervention, while the control group did not show significant changes. The study suggests that utilizing positive counseling approaches, especially through social media platforms like WhatsApp, can effectively alleviate PMS symptoms, particularly in adolescents, and may be a valuable addition to adolescent health promotion strategies. [Extracted from the article]

A study conducted by researchers at Tokyo University of Agriculture focused on the effects of consuming fermented food containing Aspergillus oryzae (Amazake or Raw-SHIOKOJI) on abdominal symptoms associated with premenstrual syndrome (PMS) in Japanese women. The study involved eleven healthy Japanese collegiate women in their 20s and found that consuming fermented food containing Aspergillus oryzae may reduce PMS abdominal symptoms by 72.7%. The research concluded that this dietary intervention could potentially improve the health and quality of life of menstruating women. [Extracted from the article]

A clinical trial, NCT06678425, aims to study the efficacy of repetitive peripheral magnetic stimulation (rPMS) on shoulder subluxation in subacute stroke patients. The trial seeks to determine if rPMS can reduce shoulder subluxation and improve upper-limb motor recovery in subacute stroke patients by comparing real rPMS to sham rPMS. Participants will receive either real or sham rPMS for 20 minutes, 5 days a week for 2 weeks, along with a conventional rehabilitation program. Follow-up assessments will be conducted at 2-, 4-, 8-, and 12-week intervals after the start of treatment. [Extracted from the article]

A recent study conducted by researchers from Benemerita Autonomous University of Puebla in Mexico focused on dysmenorrhea and premenstrual syndrome (PMS) in the Mexican population. The study aimed to evaluate the impact of health habits on these conditions and found that factors such as physical activity, changes in eating habits, and sleep patterns can predict the severity of symptoms. The researchers concluded that addressing early gynecological conditions and maintaining adequate health habits may help regulate dysmenorrhea and PMS in women. [Extracted from the article]

Researchers at the University Medical Centre have conducted a study on multiple sclerosis, a chronic inflammatory disease of the central nervous system. The study highlights the progression of the disease from acute onset to chronic phases, emphasizing the importance of understanding the pathological mechanisms of MS for effective treatment. The research also discusses current treatments for MS progression and explores potential novel treatment strategies for progressive MS. For more information, readers can refer to the original article published in Pharmaceuticals. [Extracted from the article]

The article discusses the differences between premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), as well as premenstrual exacerbation of existing mental health conditions. PMS is characterized by mild to moderate symptoms, while PMDD is a more severe form affecting 3-9% of women. Hormone fluctuations during the menstrual cycle play a role in these conditions, and treatment options include lifestyle changes, medication, therapy, and supplements. The article emphasizes the importance of open discussions about menstrual health and seeking appropriate help when needed. [Extracted from the article]

Researchers at the University of North Carolina Chapel Hill have conducted a study on premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome. The study focuses on monitoring physiological variables such as heart rate variability, sleep, and physical activity to develop an affective state prediction model for PMDD. The research suggests that remote monitoring paradigms could help in detecting affective state changes and potentially lead to more timely interventions for individuals with PMDD and other depressive disorders. The study emphasizes the importance of real-time monitoring for chronic conditions like PMDD, similar to how it has benefited the management of cardiovascular disease and diabetes. [Extracted from the article]

The article explores the relationship between wearable-measured heart rate variability (HRV) and premenstrual disorder symptoms across menstrual cycles. The study involved 193 female participants, including 68 with confirmed premenstrual disorders, with data collected from 293 menstrual cycles. The findings suggest that HRV metrics fluctuate across menstrual cycles and have varying associations with premenstrual disorder symptoms, potentially offering insights for future diagnostic processes in this area of study. [Extracted from the article]

A clinical trial, NCT06665347, is being conducted by Cairo University to evaluate the effect of yoga on the psychological aspect and quality of life in premenstrual syndrome. Premenstrual syndrome (PMS) negatively impacts young girls' lives, affecting work efficiency and school attendance. Yoga, as a form of mind-body health, aims to improve overall wellness through physical activity, mindfulness, breathing, and meditation. The study will provide evidence on the efficacy of yoga in managing PMS symptoms, contributing valuable information to the field of physical therapy. [Extracted from the article]

A patent has been issued for devices and methods for shallow depth ablation by inventors Begg and Sartor, with Covidien LP as the assignee. The patent focuses on a surgical device for shallow depth ablation, utilizing an end effector assembly with electrode arrays to conduct electrosurgical energy for tissue ablation. The device aims to address conditions such as Polycystic Ovary Syndrome (PCOS) by targeting ovarian sympathetic neural activity. [Extracted from the article]

A recent study conducted by Johns Hopkins University School of Medicine explores the connection between childhood traumatic events and premenstrual disorders (PMDs) in women. The research suggests that individuals with PMDs and premenstrual exacerbation (PME) may have experienced higher levels of childhood trauma compared to healthy controls. The study emphasizes the need for further research to understand the relationship between childhood trauma and mental health issues, as well as to develop more effective interventions for those affected. [Extracted from the article]

A study conducted by the Department of Community Health Nursing focused on premenstrual syndrome (PMS) and its management among adolescent girls. The research highlighted the importance of educating adolescent girls on managing premenstrual symptoms to prevent negative impacts on health and education. The study found that 5-20% of women experience moderate to severe premenstrual symptoms, with hormonal variations playing a role in symptom changes. The exact cause of PMS remains unknown, but lifestyle changes and proper management can help alleviate symptoms. [Extracted from the article]

A recent study conducted by researchers at Srinivas University in Karnataka, India, explored the relationship between physical activity and premenstrual syndrome (PMS) among college students. The study involved 500 female college students aged 18-30 years old, with findings indicating a significant correlation between behavioral symptoms of PMS and physical activity levels. While overall premenstrual symptoms did not show a significant correlation with physical activity, the study highlights the importance of understanding how physical activity may impact specific aspects of PMS. This research contributes valuable insights to the field of women's health and underscores the need for further exploration in this area. [Extracted from the article]

A recent study from McMaster University explores the impact of biological rhythms on premenstrual dysphoric disorders (PMDD) and premenstrual syndrome (PMS). The research suggests that women with PMDD and PMS may experience lower melatonin levels, elevated nighttime core body temperature, and poorer subjective sleep quality compared to those without these conditions. The study highlights the need for further research in this area and proposes potential mechanisms behind these findings. For more information, the full article can be accessed for free at BMC Women's Health. [Extracted from the article]

A study conducted at Heidelberg University examined the cyclicity of mood and cortisol levels in individuals with premenstrual dysphoric disorder (PMDD) and healthy controls. The research found that individuals with PMDD showed mood cyclicity, while healthy controls exhibited cortisol cyclicity. Habitual and momentary repetitive negative thinking (RNT) and present moment awareness (PMA) were found to affect mood and cortisol levels differently in both groups. The lack of cortisol cyclicity in individuals with PMDD may serve as an endocrinological marker for the disorder. [Extracted from the article]

Researchers from the Medical University of Silesia in Katowice conducted a study on the potential use of serum Vitamin D3 as a biomarker for neuronal damage in smoldering multiple sclerosis (MS). The study found that Vitamin D deficiency was associated with higher levels of certain parameters of brain injury in MS patients. The research suggests that serum Vitamin D levels, along with specific brain injury markers in cerebrospinal fluid, could serve as promising biomarkers for neurodegeneration processes in smoldering MS. [Extracted from the article]

A recent study conducted at University Hospital Basel in Switzerland analyzed the long-term effects of ocrelizumab therapy on patients with multiple sclerosis (MS). The study found that patients treated with ocrelizumab had a manageable infection risk profile, with stable incidence rates of serious infections over a median treatment period of 3.7 years. Risk factors for infections included comorbidities, recent relapse activity, and disability status. The researchers suggest that optimal disease control and addressing modifiable risk factors may help reduce the risk of infections in MS patients undergoing ocrelizumab therapy. [Extracted from the article]

A recent study conducted at Nitte Usha Institute of Nursing Sciences in Karnataka, India, focused on premenstrual syndrome (PMS) among late adolescent girls. The research found that 86% of participants experienced PMS, with 24% reporting mild symptoms, 54% moderate, and 8% severe. Lifestyle factors were identified as significant influencers of PMS, highlighting the importance of educational programs to address this health issue. For more information, readers can refer to the study published in Social Medicine. [Extracted from the article]

A recent report from the Guru Jambheshwar University of Science and Technology in Haryana, India, highlights the potential benefits of yoga therapy for premenstrual syndrome (PMS). The study found that yoga can help alleviate the physical, psychological, and behavioral symptoms associated with PMS. The research involved a systematic review and meta-analysis of randomized controlled trials, which showed that yoga therapy can reduce emotional distress, improve quality of life, and provide relief from menstrual pain, irregular periods, stress, tension, and anxiety. These findings suggest that yoga may be a valuable complementary and alternative medicine approach for managing PMS symptoms. [Extracted from the article]

Researchers from Fudan University have conducted a comparative study on the post-marketing surveillance (PMS) of cell and gene therapy products (CGTPs) in the European Union (EU), the United States (US), Japan, South Korea, and China. The study found that the regulatory policies and implementation of PMS for CGTPs in the EU, US, Japan, and South Korea were more comprehensive compared to China. The EU had dedicated regulations and guidelines for PMS, with a majority of CGTPs under additional monitoring. The US had released specific guidelines for CGTPs, including risk evaluation and mitigation strategies. Japan had stringent supervision measures, while South Korea's PMS mainly included post-surveillance activities. The study suggests that China can learn from these countries' experiences to develop a secure and standardized post-marketing regulatory framework for CGTPs. [Extracted from the article]

A clinical trial, NCT06621680, is being conducted by Cairo University in Egypt to investigate the effect of connective tissue massage on premenstrual syndrome in adolescent females. The trial will involve 50 virgin adolescent females diagnosed with premenstrual syndrome, who will receive multivitamins and connective tissue massage over a 12-week period. The primary outcome measures will include pain intensity and premenstrual syndrome severity. This article provides a reliable source of information for library patrons interested in the clinical research and health aspects of massage and musculoskeletal manipulations. [Extracted from the article]

A new study conducted in Chiba, Japan, has evaluated the efficacy of 0.5 mg dienogest tablets in treating premenstrual syndrome (PMS)-like symptoms during the treatment of dysmenorrhea. The study compared the effects of dienogest tablets with a low-dose estrogen-progestin combination. The results showed that dienogest was more effective in relieving PMS-like symptoms, with 89.7% of patients reporting complete resolution of symptoms at 6 months, compared to 47.1% in the low-dose estrogen-progestin group. However, further research is needed to determine the effectiveness of dienogest tablets in treating premenstrual disorders diagnosed through standard methods. [Extracted from the article]

A clinical trial, NCT06604728, has been launched to evaluate the effectiveness and tolerance of intravenous and subcutaneous biological drugs in gastrointestinal diseases. Biologics, such as infliximab and vedolizumab, are effective treatments for inflammatory bowel disease (IBD). The study aims to collect real-life clinical experience and describe the progress of patients who switch from intravenous to subcutaneous administration of these drugs. The choice between intravenous and subcutaneous therapy is typically based on patient preference, venous availability, and the prescribing doctor's experience. The trial is currently recruiting participants and is expected to be completed by September 2025. [Extracted from the article]

A recent study conducted by Istanbul Gedik University investigated the impact of different telerehabilitation methods on the clinical status of elderly chronic obstructive pulmonary disease (COPD) patients. The study randomly assigned 26 patients to either a pulmonary telerehabilitation (PtR) group or a cognitive telerehabilitation (CtR) group. Both groups showed statistically significant improvements in the 6-minute walk test distance and peripheral muscle strength. The study suggests that cognitive telerehabilitation can be a viable alternative for respiratory patients who cannot tolerate active exercise programs. [Extracted from the article]

A report from the University of Manchester explores the experiences and psychological impact of living with premenstrual disorders (PMDs), specifically Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD). The study found that women's accounts revealed intense and life-changing experiences with PMDs, which often required them to take on the responsibility of understanding and managing their own condition. The research recommends that professionals working with women in crisis should assess for PMDs and refer them to specialist services. The study provides valuable insights into the psychological effects of PMDs and highlights the need for improved support and understanding in healthcare settings. [Extracted from the article]

A new report from researchers at Maharishi Markandeshwar (Deemed to be University) in Haryana, India, explores the impact of premenstrual syndrome (PMS) on proprioception, reaction time, and coordination in females. The study, conducted with 998 participants aged 18-40, found significant differences in these variables between females with PMS and those without. The research suggests that females with PMS experience greater variation in proprioception, reaction time, and coordination, which can significantly affect their quality of life. The study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. [Extracted from the article]

The article discusses the significant impact of premenstrual dysphoric disorder (PMDD) on women's physical and mental health, affecting about 4%-8% of women of reproductive age. PMDD is characterized by severe cyclical discomfort that can impair daily functioning and relationships. Risk factors include family history, past trauma, smoking, chronic pain, and obesity, with a potential association with higher risk of death from non-natural causes. The article emphasizes the importance of early diagnosis, monitoring, and suicide prevention strategies for women with PMDD. [Extracted from the article]

I've also found a community of other PMDD sufferers, thanks to people like Laura Teare-Jones, a North Wales-based PMDD advocate, coach and trainer. After Taylor, who is a close friend, told me about her own diagnosis, I went to my doctor with the results of my tracking. I Have PMDD. "Just having the awareness that this is the PMDD talking, I'm now able to say to my friends, 'Hey, I'm having PMDD.'" Taylor was lucky. [Extracted from the article]

What is PMS? Premenstrual syndrome (PMS) is the name for a group of symptoms that you may experience up to 14 days before your period (menstruation). The symptoms usually stop [...]

2023 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on premenstrual syndrome. According to news reporting originating from Padova, [...]

The article offers brief information on several natural health products for women's health including the Multi Collagen Protein from Ancient Nutrition, the EstroSense hormone balancing therapy from Womensense, and the Women's Everyday Probiotic from Orange Naturals.